The performance of companies tied to iconic drugs like Viagra presents a nuanced investment landscape . While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key markets has introduced considerable volatility. Investors are now facing the impact of rival medications , diminish